EZRMFGF21

Rat/Mouse FGF-21 ELISA Kit

measures and quantifies FGF-21 levels in 10 µl - 20 µl serum, plasma or cell culture supernatent

• 別名: Fibroblast growth factor 21
• UNSPSCコード: 12161503
• eCl@ss: 32161000
• NACRES: NA.32

特性

• 製品名: Rat / Mouse FGF-21 ELISA Kit, This Rat / Mouse FGF-21 ELISA Kit is used to measure & quantify FGF-21 levels in Metabolism & Inflammation & Immunology research.
• 品質水準: 200
• 化学種の反応性: mouse, rat
• 包装: kit of 1 × 96 wells
• パラメーター: 10—20 μL sample volume (4hr assay)
• assay range: standard curve range: 50-12000 pg/mL; inter-assay cv: <8%; intra-assay cv: <10%
• テクニック: ELISA: suitable
• 入力: sample type cell culture supernatant; sample type serum; sample type plasma (K2 EDTA)
• アプリケーション: research use
• 検出方法: colorimetric (450nm/590nm)
• 輸送温度: wet ice
• 保管温度: 2-8°C

詳細

詳細

Recent studies have demonstrated that fibroblast growth factor 21 (FGF-21), a liver derived protein, is able to increase glucose uptake, as well as lower plasma triglyceride levels in an insulin-independent manner. FGF-21 suppresses glucagon release, thereby increasing insulin sensitivity, and reduces the amount of insulin production by pancreatic β-cells. Unlike insulin, which works in a rapid, hormone-like manner, FGF-21 activity requires several hours, indicating changes in gene expression. No significant weight gain was observed when FGF-21 was injected into animals, and mice that had been genetically engineered to overexpress FGF-21 weighed less and had less adipose tissue than the normal controls.

Although considerable progress has been made in the understanding of the pathobiology of type 2 diabetes, as well in the development of new compounds for the treatment of diabetic patients, this disease remains a major global health concern. Consequently, Millipore is pleased to offer the Rat/Mouse FGF-21 ELISA kit for the quantification of FGF-21 in rat and mouse serum and plasma samples. The insulin-independent activities of FGF-21, as well as the absence of the weight gain effects of insulin, thiazolidinediones and other anti-diabetic drugs, distinguish it from current insulin-sensitizing drugs, making it a promising therapeutic.

特異性

Cross-reactivity to Human FGF-21: 39%

No significant cross-reactivity to the cytokines and metabolic hormones tested was observed.

アプリケーション

Research Category
代謝

Research Sub Category
2型糖尿病

メタボリックシンドローム

This is a 3-hour assay requiring 20 μL (in duplicate) of rat sample or 10µl (in duplicate) of mouse sample.

Used to detect/quantify: FGF-21

その他情報

Please contact Technical Service for linearity of dilution.

免責事項

For research use only. Not for use in diagnostic procedures.

安全性情報

• ピクトグラム: GHS06,GHS05,GHS09
• シグナルワード: Danger
• 危険有害性情報: H290,H302 + H332,H311,H317,H319,H335,H411
• 注意書き: P273 - P280 - P301 + P312 - P302 + P352 + P312 - P304 + P340 + P312 - P305 + P351 + P338
• 危険有害性の分類: Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2 - Met. Corr. 1 - Skin Sens. 1 - STOT SE 3
• ターゲットの組織: Respiratory system
• 保管分類コード: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects